Skip to main content
MedWatcherBeta

Loading research and source information…

A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH) for Fatty liver disease and MASH: evidence and status · MedWatcher